Back

Renal hyperfiltration as risk factor of major adverse cardiovascular events in patients with acute myocardial infarction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Coronary artery disease in kidney patients: from genes to treatment Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Weon Kim

Kyung Hee Medical Center, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Characterization of individuals with atherosclerotic cardiovascular disease, with and without chronic kidney disease: results from a UK electronic health record database
Professor N. Sattar (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Coronary artery disease screening in renal transplant candidates: insights from a large prospective cohort
Mr L. Giovachini (Paris, FR)
Abstract Slides Video
Presentation thumbnail
The effect of the combined treatment with dulaglutide and dapagliflozin in arterial elasticity, cardiac function, albuminuria and endothelial thickness in type 2 diabetes mellitus after 12 months
Doctor I. Ikonomidis (Athens, GR) Doctor K. Katogiannis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Mapping renal impairment and cardiac structure and function: observation and genetic insights from 30,000 cardiac magnetic resonance images
Doctor X. Lu (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease
Doctor O. Dirir (Sheffield, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary artery disease in kidney patients: from genes to treatment
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources